19/12/2014 19:49:44 Free Membership Login

   

Alexza

Visual Financials
Company Name: Alexza Pharmaceuticals, Inc.
Ticker Symbol: ALXA
WWW Address: http://www.alexza.com
CEO: Thomas King
No. of Employees: 63
Common Issue Type: CS
Business Description:Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 1.44 Up 0.09 1.45 1.85 1.38 1.50 1.34 128138
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 27.9 19.4 0.00 -2.38 0.00 0.0 0.0 5.93 - 1.24
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close1.44$
PE Ratio - LTM0.0
Market Capitalisation27.9mil
Latest Shares Outstanding19.4mil
Earnings pS (EPS)-2.38$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float17.0mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.40%
Gross Profit Margin76.6%
EBITDA Margin-72.7%
Pre-Tax Profit Margin0.0%
Assets Turnover109.2%
Return on Assets (ROA)-90.4%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio2.1
Leverage Ratio (Assets/Equity)
Interest Cover-25.4
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.83$
Cash pS0.00$
Book-Value pS-2.52$
Tangible Book-Value pS-1.24$
Cash Flow pS-2.60$
Free Cash Flow pS-2.77$
KEY FIGURES (LTM): Price info
Price/Book Ratio-0.54
Price/Tangible Book Ratio0.00
Price/Cash Flow-0.5
Price/Free Cash Flow-0.5
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.554.94-72-4
4 Weeks1.501.341.341.554.941-50
13 Weeks1.441.441281381.245.931-50
26 Weeks1281381.551.551.455.931-7
52 Weeks1.241.241.542.961.242-7
YTD1.241.24-2.961.24-71
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
1.241.242.692.695.270.320.32
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue177628810607441060744
Income177628817762886667463
Dividend66674631655233816552338
Capital Spending29239532NA29239532
R&D1383025NA1383025
Normalized Inc.6667463NA6667463
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-75-84-84
Earnings %-84-84-85
EPS %989595
EPS $-859595
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio47072000
Quick Ratio (Acid Test)16159000
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS-23975000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)3789000
Debt Ratio71047000
Total Debt/Equity (Gearing Ratio)FI
LT Debt/Equity39000000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities71047000
Interest Cover-28967000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM16,596,447.00
Enterprise Value (EV)/EBITDA-0.00
Enterprise Value (EV)/Free Cash Flow24.95
Dividend Yield454389
Price/Tangible Book Ratio - LTM46
Price/Book Ratio - LTM116755
Price/Cash Flow Ratio2.1
Price/Free Cash Flow Ratio - LTM46
Price/Sales Ratio1.00
P/E Ratio (1 month ago) - LTM16596447
P/E Ratio (26 weeks ago) - LTM22752905
P/E Ratio (52 weeks ago) - LTM22752905
5-Y High P/E Ratio29422278
5-Y Low P/E Ratio28687082
5-Y Average P/E Ratio96921
Current P/E Ratio as % of 5-Y Average P/E96921
P/E as % of Industry Group88,814.0
P/E as % of Sector Segment88,814.0
Current 12 Month Normalized P/E Ratio - LTM96,431.0
PER SHARE FIGURES
LT Debt pS11524000
Current Liabilities pS
Tangible Book Value pS - LTM2.1
Book Value pS - LTM116755
Capital Invested pS0.00
Cash pS - LTM4331
Cash Flow pS - LTM5.96
Free Cash Flow pS - LTM5.96
Earnings pS (EPS)-38
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-28967000
Net Profit Margin - 5YEAR AVRG.2014-11-01
Equity Productivity0.00
Return on Equity (ROE)-23975000
Return on Equity (ROE) - 5YEAR AVRG.26196340
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.83
Assets Productivity3,789,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.26196340
Gross Profit Margin88814
Gross Profit Margin - 5YEAR AVRG.83
EBITDA Margin - LTM104179
EBIT Margin - LTM88814
Pre-Tax Profit Margin14991000
Pre-Tax Profit Margin - 5YEAR AVRG.19404697
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle14,898,151
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio14898000
Inventory Turnover
Inventory/Sales11524000
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover3789000
Revenue per $ Cash4914000
Revenue per $ Plant4914000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.19404697
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxa141219 19:49